Century Therapeutics, Inc.IPSCNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-6.4%
5Y CAGR+19.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-6.4%/yr
Annual compound
5Y CAGR
+19.2%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $114.08M | -21.2% |
| 2024 | $144.73M | -2.7% |
| 2023 | $148.78M | +7.0% |
| 2022 | $139.03M | +54.0% |
| 2021 | $90.30M | +90.4% |
| 2020 | $47.42M | +139.7% |
| 2019 | $19.78M | - |